Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: Interactions with the neutral and cationic amino acid transporter on the corneal epithelium

References

• Sinkula AA, Yalkowsky SH. Rationale for design of biologically reversible drug derivatives: Prodrugs. J Pharm Sci.1975;64:181–210.
   PubMed Web of Science ®Google Scholar
• Stella VJ, Charman WN, Naringrekar VH. Prodrugs. Do they have advantages in clinical practice? Drugs.1985;29:455–473.
   Google Scholar
• Dantzig AH, Bergin L. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim Biophys Acta.1990;1027:211–217.
   PubMed Web of Science ®Google Scholar
• Inui K, Yamamoto M, Saito H. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: Specific transport systems in apical and basolateral membranes. J Pharmacol Exp Ther.1992;261: 195–201.
   Google Scholar
• Hashimoto N, Fujioka T, Toyoda T, Muranushi N, Hirano K. Renin inhibitor: Transport mechanism in rat small intestinal brush-border membrane vesicles. Pharm Res.1994;11:1448–1451.
   Google Scholar
• Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP, Oh DM, Sadee W, Amidon GL. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res.1998;15:1154–1159.
   PubMed Web of Science ®Google Scholar
• Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA, Hammond JR. Molecular cloning and functional character-ization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem J.2000;352(Pt 2):363–372.
   PubMed Web of Science ®Google Scholar
• Christensen HN. Role of amino acid transport and coun-tertransport in nutrition and metabolism. Physiol Rev.1990;70:43–77.
   PubMed Web of Science ®Google Scholar
• Smith QR, Stoll J. Blood-brain barrier amino acid trans-port. In: Introduction to the Blood-Brain Barrier. W.M. Pardridge, editor. Cambridge: Cambridge University Press; 1988:188–197.
   Google Scholar
• Saito H, Okuda M, Terada T, Sasaki S, Inui K. Cloning and characterization of a rat H+/peptide cotransporter mediat-ing absorption of beta-lactam antibiotics in the intestine and kidney. J Pharmacol Exp Ther.1995;275:1631–1637.
   Google Scholar
• Tsuji A, Tamai I. Carrier-mediated intestinal transport of drugs. Pharm Res.1996;13:963–977.
   PubMed Web of Science ®Google Scholar
• Oh DM, Han HK, Amidon GL. Drug transport and targeting. Intestinal transport. Pharm Biotechnol.1999;12:59–88.
   Google Scholar
• Lee VH. Membrane transporters. Eur J Pharm Sci.2000;1 l\(Suppl 2):541–50.
   Google Scholar
• Tamai I, Tsuji A. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci.2000;89:1371–1388.
   PubMed Web of Science ®Google Scholar
• Zhou X, Thamotharan M, Gangopadhyay A, Serdikoff C, Adibi SA. Characterization of an oligopeptide transporter in renal lysosomes. Biochim Biophys Acta.2000;1466:372–378.
   PubMed Web of Science ®Google Scholar
• Anand BS, Dey S, Mitra AK. Current prodrug strategies via membrane transporters/receptors. Expert Opin Biol Ther.2002;2:607–620.
   PubMed Web of Science ®Google Scholar
• Dey S, Anand BS, Patel J, Mitra AK. Transporters/recep-tors in the anterior chamber: pathways to explore ocular drug delivery strategies. Exp Opin Biol Ther.2003;3: 23–44.
   PubMed Web of Science ®Google Scholar
• Anand BS, Mitra AK. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide trans-porter on the rabbit cornea. Pharm Res.2002;19:1194–1202.
   PubMed Web of Science ®Google Scholar
• Jain-Vakkalagadda B, Dey S, Pal D, Mitra AK. Identifica-tion and functional characterization of a No+ independent large neutral amino acid transporter LAT1 on rabbit cornea. Inv Ophthalmol Vis Sci.2003;44: 2919–2927.
   Google Scholar
• Jain-Vakkalagadda B. Identification and functional charac-terization of amino acid transporters on the corneal epithe-lium: A strategy to enhance the corneal permeation of antiviral drug acyclovir. In: Thesis in Pharmaceutical Sciences,University of Missouri-Kansas City, Kansas City, 2002.
   Google Scholar
• Bildin VN, Iserovich P, Fischbarg J, Reinach PS. Differen-tial expression of Na:K :2C1 cotransporter, glucose trans-porter 1, and aquaporin 1 in freshly isolated and cultured bovine corneal tissues. Exp Biol Med (Maywood).2001;226:919–926.
   PubMed Web of Science ®Google Scholar
• Ishida K, Yamashita H, Katagiri H, Oka Y. Regulation of glucose transporter 1 (GLUT1) gene expression by epider-mal growth factor in bovine corneal endothelial cells. Jpn J Ophthalmol.1995;39:225–232.
   PubMedGoogle Scholar
• Takahashi H, Kaminski AE, Zieske JD. Glucose transporter 1 expression is enhanced during corneal epithelial wound repair. Exp Eye Res.1996;63: 649–659.
   Google Scholar
• Takahashi H, Ohara K, Ohmura T, Takahashi R, Zieske JD. Glucose transporter 1 expression in corneal wound repair under high serum glucose level. Jpn J Ophthalmol.2000;44: 470–474.
   Google Scholar
• Majumdar S, Gunda S, Mitra AK. Functional expression of a sodium dependent nucleoside transporter on rabbit cornea: Role in corneal permeation of Acyclovir and Idox-uridne . Curr Eye Res.2003;26:175–183.
   Google Scholar
• Majumdar S, Tirucherai GS, Pal D, Mitra AK. Functional differences in nucleoside and nucleobase transporters expressed on the rabbit corneal epithelial cell line (SIRC) and isolated rabbit cornea. AAPS Pharm Sci.2003;5: 145–158.
   Google Scholar
• Hughes PM, Krishriamoorthy R, Mitra AK. Effect of acy-lation on the ocular disposition of acyclovir. I: Synthesis, physicochemical properties, and antiviral activity of 2'-esters. J Ocul Pharmacol.1993;9: 287–297.
   Google Scholar
• Anand BS, Nashed YE, Mitra AK. Novel dipeptide pro-drugs of acyclovir for ocular herpes infections: Biorever-sion, antiviral activity and transport across rabbit cornea. Curr Eye Res.2003;26:151–163.
   Google Scholar
• Anand BS, Hill JM, Dey S, Maruyama K, Bhattacharjee PS, Myles ME, Nashed YE, Mitra AK. In vivo antiviral effi-cacy of a dipeptide acyclovir prodrug, Val-Val-acyclovir against HSV-1 epithelial and stromal keratitis in the rabbit eye model. Inv Ophthalmol Vis Sci.2003;44:2529–2534.
   PubMed Web of Science ®Google Scholar
• Nashed YE, Mitra AK. Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir. Spectrochim Acta A Mol Biomol Spectrosc.2003;59:2033–2039.
   PubMed Web of Science ®Google Scholar
• Tak RV, Pal D, Gao H, Dey S, Mitra AK. Transport of acy-clovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. J Pharm Sci.2001;90: 1505–1515.
   Google Scholar
• Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (ISO) of an enzymatic reac-tion. Biochem Pharmacol.1973;22:3099–3108.
   PubMed Web of Science ®Google Scholar
• Sloan JL, Mager S. Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J Biol Chem.1999; 274:23740–23745.
   PubMed Web of Science ®Google Scholar
• Deves R, Boyd CA. Transporters for cationic amino acids in animal cells: Discovery, structure, and function. Physiol Rev.1998;78:487–545.
   PubMed Web of Science ®Google Scholar
• White MF, Gazzola GC, Christensen HN. Cationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblasts. J Biol Chem.1982;257:4443–4449.
   Google Scholar
• Christensen HN, Antonioli JA. Cationic amino acid trans-port in the rabbit reticulocyte. Na+-dependent inhibition of Na+-independent transport. J Biol Chem.1969;244:1497–1504.
   Google Scholar
• Van Winkle LJ, Christensen HN, Campione AL. Na+-dependent transport of basic, zwitterionic, and bicyclic amino acids by a broad-scope system in mouse blastocysts. J Biol Chem.1985;260:12118–12123.
   Google Scholar
• Van Winkle LJ, Campione AL, Gorman JM. Na+-independent transport of basic and zwitterionic amino acids in mouse blastocysts by a shared system and by processes which distinguish between these substrates. J Biol Chem.1988;263:3150–3163.
   Google Scholar
• Deves R, Chavez P, Boyd CA. Identification of a new transport system (y + L) in human erythrocytes that recognizes lysine and leucine with high affinity. J Physiol.1992;454:491–501.
   Google Scholar
• Kanai Y, Endou H. Heterodimeric amino acid trans-porters: Molecular biology and pathological and pharmacological relevance. Curr Drug Metab.2001 ;2:339–354.
   PubMed Web of Science ®Google Scholar